The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
The Joint Corp.NASDAQ: JYNT
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities falls 29.3% from a year ago
Other current liabilities stood at $24.35M at the end of Q1 FY2026, down 29.3% from a year earlier and up 7.3% from the prior quarter. Over 3 fiscal years it compounded at +152.9% a year.
Context
- Other current liabilities amounted to 42.0% of total assets at the end of Q1 FY2026, down 2.6 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -29.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 22.68M USD
- Year-over-year change
- -42.1%
- 4-year CAGR
- +122.5%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 22.68M | -42.1% |
| FY2024 | 2024-12-31 | 39.2M | +43.2% |
| FY2023 | 2023-12-31 | 27.37M | +1851.6% |
| FY2022 | 2022-12-31 | 1.4M | +51.5% |
| FY2021 | 2021-12-31 | 925.72K | — |
Other Current Liabilities vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's Mar 2026 other current liabilities of $24.35M is the 2nd highest of the 11 companies compared; the peer median is $2.61M.
- Its year-over-year change of -29.3% is the 7th highest of 10, against a peer median of -17.0%.
- Other current liabilities amounts to 42.0% of total assets for JYNT, versus a peer median of 5.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $29.3M | +8.4% | -21.5% | 14.0% | |
| Mar 2026 | $24.35M | -29.3% | +152.9% | 42.0% | |
| Mar 2026 | $7.63M | +162.0% | -15.9% | 8.8% | |
| Mar 2026 | $5.05M | -82.6% | +74.7% | 5.7% | |
| Mar 2026 | $3.84M | -18.8% | — | 6.1% | |
| Mar 2026 | $3.03M | +13.5% | -4.5% | 4.9% | |
| Mar 2026 | $2.2M | — | -28.3% | 6.5% | |
| Mar 2026 | $1.23M | -62.3% | — | 0.7% | |
| Mar 2026 | $1.2M | -14.9% | +41.3% | 1.3% | |
| Mar 2026 | $637.73K | -91.8% | -4.0% | 0.4% | |
| Mar 2026 | $498K | -17.0% | +21.7% | 1.4% | |
| Peer median (excluding JYNT) | $2.61M | -17.0% | -4.3% | 5.3% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 19.53M | 9.75M | 18.15M | 25.05M | 23.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 3.7M | 3.91M | 2.58M | 2.59M | 2.85M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.38M | 3.96M | 23.6M | 46.94M | 25.64M |
| Total Current Assets | 26.89M | 17.61M | 44.34M | 74.58M | 52.09M |
| Property, Plant & Equipment (Net) | 32.81M | 38.06M | 4.27M | 3.76M | 4.73M |
| Goodwill | 5.09M | 8.49M | 7.35M | 0 | 0 |
| Intangible Assets | 4.71M | 10.93M | 5.02M | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 11.49M | 11.93M | 1.03M | 0 | 0 |
| Other Non-current Assets | 6.07M | 6.46M | 25.19M | 4.81M | 4.15M |
| Total Non-current Assets | 60.17M | 75.88M | 42.87M | 8.58M | 8.88M |
| Total Assets | 87.06M | 93.49M | 87.21M | 83.15M | 60.97M |
| Account Payables | 1.71M | 2.97M | 1.25M | 1.75M | 1.59M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 8.43M | 10.43M | 2.52M | 2.55M | 2.8M |
| Other Current Liabilities | 925.72K | 1.4M | 27.37M | 39.2M | 22.68M |
| Total Current Liabilities | 21.44M | 23.22M | 33.57M | 49.04M | 32.82M |
| Long-term Debt | 2M | 2M | 2M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 57.15K | 0 | 0 |
| Deferred Revenue (Non-current) | 12.95M | 14.16M | 13.6M | 12.45M | 10.9M |
| Other Non-current Liabilities | 3.4M | 2.79M | 12.76M | 672.33K | 355.56K |
| Total Non-current Liabilities | 35.31M | 37.69M | 28.86M | 13.43M | 13.07M |
| Total Liabilities | 56.75M | 60.9M | 62.44M | 62.48M | 45.89M |
| Common Stock | 14.45K | 14.56K | 14.78K | 15.19K | 15.47K |
| Retained Earnings | (12.78M) | (12.15M) | (21.91M) | (27.7M) | (24.8M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 25K | 25K | 25K | 25K | 25K |
| Total Equity | 30.31M | 32.59M | 24.77M | 20.68M | 15.08M |
| Total Debt | 23.62M | 26.06M | 2.86M | 795.03K | 2.01M |
| Net Debt | 4.1M | 16.31M | (15.29M) | (24.26M) | (21.59M) |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.